Home > Financial Ratios > GENNEX LABORATORIES

GENNEX LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for GENNEX LABORATORIES
Please provide your vote to see the results

GENNEX LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 23.75153.7027.91-4.2368.10

What is the latest Core EBITDA Growth ratio of GENNEX LABORATORIES ?

The latest Core EBITDA Growth ratio of GENNEX LABORATORIES is 23.75 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202523.75
Mar2024153.70
Mar202327.91
Mar2022-4.23
Mar202168.10

How is Core EBITDA Growth of GENNEX LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2025 23.75
-84.55
Mar2024 153.7
450.70
Mar2023 27.91
Positive
Mar2022 -4.23
Negative
Mar2021 68.1 -

Other Financial Ratios of GENNEX LABORATORIES


Compare Core EBITDA Growth ratio of peers of GENNEX LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENNEX LABORATORIES ₹262.3 Cr 3.3% 13.6% -19.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,428.0 Cr 1.5% -3% 6.7% Stock Analytics
DIVIS LABORATORIES ₹175,426.0 Cr -2.2% -4.5% 0.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,603.0 Cr 0.8% 2.3% 43.9% Stock Analytics
CIPLA ₹111,604.0 Cr 0.4% -4% -7.8% Stock Analytics
DR REDDYS LABORATORIES ₹106,775.0 Cr 0.8% -1.8% -3.4% Stock Analytics


GENNEX LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENNEX LABORATORIES

3.3%

13.6%

-19.7%

SENSEX

3.7%

2.2%

-7.2%


You may also like the below Video Courses